Comoros vs Ecuador: Access to anti-retroviral drugs, female
Comoros
74.0%
in 2024
Ecuador
75.0%
in 2024
Comoros rank
69th
Ecuador rank
67th
Access to anti-retroviral drugs, female over time
- Comoros
- Ecuador
How they compare
Ecuador currently reports 75.0% against 74.0% in Comoros, a difference of 1.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Ecuador ahead.
Comoros ranks 69th and Ecuador ranks 67th of 141 countries.
Across the 3 decades both report, Comoros averaged higher in 1 and Ecuador in 2.
Head to head by decade
| Decade | Comoros | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 5.3% | 5.3% | Ecuador |
| 2010s | 42.4% | 38.7% | 3.7% | Comoros |
| 2020s | 70.2% | 71.6% | 1.4% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Comoros or Ecuador?
- Ecuador, at 75.0% against 74.0% in Comoros as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Comoros and Ecuador?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Comoros and Ecuador?
- 25 years are reported by both, from 2000 to 2024.
- How do Comoros and Ecuador rank globally for access to anti-retroviral drugs, female?
- Comoros ranks 69th and Ecuador ranks 67th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.